IBRUTINIB PLUS PALBOCICLIB HAS EFFICACY IN MANTLE CELL LYMPHOMA

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2019年 / 9卷 / 03期
关键词：
D O I：
10.1158/2159-8290.CD-RW2019-016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The BTK inhibitor ibrutinib plus the CDK4 inhibitor palbociclib achieves responses in 67% of MCL patients. © 2019 American Association for Cancer Research.
引用
收藏
页码：318 / 318
页数：1
相关论文
共 50 条
  • [41] Ibrutinib to Allogenic Stem Cell Transplant in a Case of Refractory Mantle Cell Lymphoma
    Rayaz Ahmed
    Jyotsna Kapoor
    Narendra Agrawal
    Priyanka Verma
    Dinesh Bhurani
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 360 - 361
  • [42] Mantle cell lymphoma: poor prognosis of patients progressing under ibrutinib
    Machet, Antoine
    Cayssials, Emilie
    Leleu, Xavier
    Guidez, Stephanie
    HEMATOLOGIE, 2016, 22 (04): : 252 - +
  • [43] Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly
    Ruella, Marco
    Soubeyran, Pierre
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 432 - 436
  • [44] Ibrutinib-a new standard treatment for relapsed mantle cell lymphoma?
    Martin, Peter
    LANCET, 2016, 387 (10020): : 728 - 729
  • [45] Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects
    Hershkovitz-Rokah, Oshrat
    Pulver, Dana
    Lenz, Georg
    Shpilberg, Ofer
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (03) : 306 - 319
  • [46] Targeting Oxphos Pathway Against Ibrutinib Resistance to Mantle Cell Lymphoma
    Liu, Yang
    Bell, Taylor
    Zhang, Hui
    Sun, Yuting
    Li, Carrie J.
    Feng, Ningping
    Huang, Shengjian
    Guo, Hui
    Wang, Jack
    Ahmed, Makhdum
    Zhang, Victoria
    Lam, Laura T.
    Nomie, Krystle
    Zhang, Liang
    Di Francesco, Maria E.
    Marszalek, Joe
    Wang, Michael
    BLOOD, 2016, 128 (22)
  • [47] Ibrutinib treatment of mantle cell lymphoma complicated by progressive multifocal leukoencephalopathy
    Mosna, Kristina
    Ladicka, Miriam
    Drgona, Lubos
    Vranovska, Martina
    Hojsikova, Ivana
    Tomasova, Radka
    Danihel, Ludovit, Jr.
    Kyselovic, Jan
    Babal, Pavel
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (06) : 343 - 350
  • [48] How should we use ibrutinib in patients with mantle cell lymphoma?
    Jerkeman, Mats
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 445 - 446
  • [49] Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma
    Karmali, Reem
    Abramson, Jeremy S.
    Stephens, Deborah M.
    Barnes, Jeffrey
    Winter, Jane N.
    Ma, Shuo
    Gao, Juehua
    Kaplan, Jason
    Petrich, Adam M.
    Hochberg, Ephraim
    Takvorian, Tak
    Mi, Xinlei
    Nelson, Valerie
    Gordon, Leo I.
    Pro, Barbara
    BLOOD ADVANCES, 2023, 7 (23) : 7361 - 7368
  • [50] Pirtobrutinib: a promising therapy for overcoming the resistance of ibrutinib in mantle cell lymphoma
    Fatima, Sania Kaneez
    Khan, Sara
    Mughal, Zaib Un Nisa
    Rangwala, Hussain Sohail
    Rangwala, Burhanuddin Sohail
    Siddiq, Mohammad Arham
    Ali, Mirha
    Farah, Asma Ahmed
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (06): : 3189 - 3191
12345